The global Blood Glucose Monitoring System Market is experiencing a major shift, with new developments and innovations shaping its future. With the surge in global prevalence of diabetes, prominent players are boosting their market positions with continuous innovations and strategic initiatives. ​

Top 5 Companies by Market Share

Abbott Laboratories:

Established in 1888 and located in Illinois, USA, Abbott is a leading company in the BGMS market. Their FreeStyle Libre system has disrupted diabetes care by providing continuous glucose monitoring (CGM) that doesn’t require regular finger sticks. The company's commitment to being at the pinnacle of diagnostic systems and at-home testing systems is evidence by it's impressive line of current and developing products. ​

Medtronic plc :

Medtronic, the global leader in medical technology, services, and solutions, is driven by a mission to alleviate pain, restore health, and extend life for patients. Its Diabetes Operating Unit is dedicated to developing innovative products and solutions for managing both Type 1 and Type 2 diabetes, including the Guardian Connect system. In fiscal 2023, Medtronic posted over $30 billion in revenue, and the Diabetes segment accounted for about $3 billion. ​

MannKind Corporation:

MannKind Corporation manufactures blood glucose meters and test strips, including the Afrezza inhaler, focusing on diabetes management in partnership with big pharmaceutical companies. Stiffness in BGMS market due to strong dispersion network and concentration on quality. ​

Dexcom, Inc.:

Based in San Diego, California, Dexcom's area of expertise is CGM systems, including g6 and G7 systems. A leader in the CGM space, they have gained notoriety for their accuracy, access to real-time data, and integration with digital health platforms. ​

Ascensia Diabetes Care:

Drug major PHC Holdings had acquired Bayer Diabetes Care to create Ascensia to make blood glucose meters under the Contour Next brand. It focuses on being accurate, easy to use, and affordable in order to reach as many customers as possible. ​

Request Sample Link :  https://www.maximizemarketresearch.com/request-sample/263715/ 

Recent Mergers and Acquisitions

The BGMS market has been characterized by strategic mergers and acquisitions that have facilitated the all-round expansion of product portfolios and the expansion of market segments. In February 2023, for instance, Ascensia Diabetes Care entered into a global partnership with SNAQ, a mobile application that provides nutritional insights for diabetes management. This partnership What are intended to deliver Holistic diabetes management solutions that combine blood glucose monitoring with dietary tracking. ​

Recent Developments in the Market

Companies are vigorously introducing new products and making partnerships to meet changing market needs:​

Abbott Laboratories: Abbott's FreeStyle Libre 3 and FreeStyle Libre 2 iCGM system sensors were approved in the U.S. FDA in 2023 the integration of the iCGM system sensors with automated insulin delivery systems. The approval is added to Abbott’s CGM systems as integral to complete diabetes management. ​

Dexcom, Inc.: Dexcom's Stelo officially became the first over the counter continuous glucose monitor to receive FDA approval in March 2024. For those with Type 2 diabetes or prediabetes who are not taking insulin, Stelo provides details on the impact of lifestyle on blood sugar and delivers real-time readings of glucose. ​

Medtronic plc: This August, Medtronic announced that it had received FDA approval for its new CGM device, the Simplera, which will integrate with the company’s Smart Multiple Daily Injection system. Also, it's working with Abbott Diabetes Care on manufacturing sensors for future CGM devices intended for use with Medtronic products. ​

New Funding or Investments

Large amounts of investment have been made to drive innovation and growth in the BGMS sector:​

Dexcom and OURA: In December 2024, Dexcom announced plans to partner with OURA, creators of smart rings, to combine Dexcom’s glucose monitoring with OURA's heart rate, activity, sleep, and stress tracking. Dexcom is also investing $75 million in OURA and the two companies plan to co-market their products, allowing users to access health data in one place. ​

Conclusion

The Blood Glucose Monitoring System market is segmented : Global Blood Glucose Monitoring System Market, By Type (Self Monitoring Type, And Continuous Glucose Monitoring), By Application (Hospital, Clinic, Home, And others) Global Blood Glucose Monitoring System Market, Region Regional analysis includes The Middle East and Africa, North America, South America, Asia Pacific, and Europe. Forward-leaning companies are also creating advanced user-friendly products through research and development that appeal to the changing needs of individuals managing diabetes. Such strategic initiatives are improving product efficiency and usability, giving these companies a significant advantage over the competition, helping them in such a competitive and fast-growing market scenario.